60 DEGREES PHARMACEUTICALS, INC. (SXTP) Operating income 2022–2025
60 DEGREES PHARMACEUTICALS, INC. (SXTP) annual operating income history from SEC filings — each fiscal year as reported.
-$7.8MFY2025 · since FY2022: -$1.8M → -$7.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$7.8M | +20.1% |
| FY2024 | -$9.7M | -88.5% |
| FY2023 | -$5.2M | -194.5% |
| FY2022 | -$1.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SXTP financial trends
SXTP RevenueSXTP Net incomeSXTP Net marginSXTP Gross profitSXTP Gross marginSXTP Operating marginSXTP Operating cash flowSXTP Free cash flowSXTP Capital expendituresSXTP Return on equitySXTP Stock buybacksSXTP Dividends paidSXTP Total assetsSXTP Total liabilitiesSXTP Shareholders’ equitySXTP overview →